Latest filing published 01 May 2026 for Spyre Therapeutics, Inc., €1.3M.
Filing timeline
BuySaleInsider track record
Sheldon Sloan: trading record in brief
This profile gathers the share dealings of Sheldon Sloan in Spyre Therapeutics, Inc. Between 1 April 2026 and 1 May 2026, the trades on record add up to 10 filings.
On the market, this insider has only sold: 8 sales, €5.1M in total. The rest of the record consists of 2 option exercises.
The latest filing, published on 1 May 2026, reports an open-market sale of €1.3M in Spyre Therapeutics, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sheldon Sloan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,306 shares@ US$69.530.019% mcap17.8% of flowCommon StockSEC:0002038798-26-000004:1
- 78,333 shares@ US$27.460.027% mcap25.8% of flowCommon StockSEC:0002038798-26-000004:0
- 19,656 shares@ US$70.610.018% mcap16.7% of flowCommon StockSEC:0002038798-26-000004:2
- 8,777 shares@ US$71.560.0080% mcap7.5% of flowCommon StockSEC:0002038798-26-000004:3
- 12,777 shares@ US$72.940.012% mcap11.2% of flowCommon StockSEC:0002038798-26-000004:4
- 10,358 shares@ US$73.740.0097% mcap9.2% of flowCommon StockSEC:0002038798-26-000004:5
- 5,059 shares@ US$74.600.0048% mcap4.5% of flowCommon StockSEC:0002038798-26-000004:6
- 400 shares@ US$75.370.0004% mcap0.4% of flowCommon StockSEC:0002038798-26-000004:7
- 7,958 shares@ US$21.662.1% of flowCommon StockSEC:0001636282-26-000030:0
- 7,958 shares@ US$50.004.8% of flowCommon StockSEC:0001636282-26-000030:1
10 of 10 declarations
